MY148077A - Antimicrobial composition - Google Patents

Antimicrobial composition

Info

Publication number
MY148077A
MY148077A MYPI2010000038A MYPI20100038A MY148077A MY 148077 A MY148077 A MY 148077A MY PI2010000038 A MYPI2010000038 A MY PI2010000038A MY PI20100038 A MYPI20100038 A MY PI20100038A MY 148077 A MY148077 A MY 148077A
Authority
MY
Malaysia
Prior art keywords
antimicrobial composition
drug
wounds
sorbent
seratiopeptidase
Prior art date
Application number
MYPI2010000038A
Other languages
English (en)
Inventor
Olga O Biliaieva
Viacheslav V Neshta
Original Assignee
Golub Alexandr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golub Alexandr A filed Critical Golub Alexandr A
Publication of MY148077A publication Critical patent/MY148077A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/2404—Serralysin (3.4.24.40)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Composite Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MYPI2010000038A 2007-07-12 2008-07-11 Antimicrobial composition MY148077A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200707897U UA28103U (uk) 2007-07-12 2007-07-12 Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків

Publications (1)

Publication Number Publication Date
MY148077A true MY148077A (en) 2013-02-28

Family

ID=55588706

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010000038A MY148077A (en) 2007-07-12 2008-07-11 Antimicrobial composition

Country Status (23)

Country Link
US (4) US9302027B2 (OSRAM)
EP (2) EP2277559A1 (OSRAM)
JP (1) JP5464750B2 (OSRAM)
KR (1) KR101482960B1 (OSRAM)
CN (1) CN101772356B (OSRAM)
AT (1) ATE488255T1 (OSRAM)
AU (1) AU2008275852B2 (OSRAM)
BR (1) BRPI0814549B1 (OSRAM)
CA (1) CA2693087C (OSRAM)
CY (1) CY1111652T1 (OSRAM)
DE (1) DE602008003584D1 (OSRAM)
DK (1) DK2170415T3 (OSRAM)
EA (1) EA016764B1 (OSRAM)
ES (1) ES2353683T3 (OSRAM)
HR (1) HRP20110107T1 (OSRAM)
MX (1) MX2010000367A (OSRAM)
MY (1) MY148077A (OSRAM)
PL (1) PL2170415T3 (OSRAM)
PT (1) PT2170415E (OSRAM)
SI (1) SI2170415T1 (OSRAM)
UA (1) UA28103U (OSRAM)
WO (1) WO2009008851A2 (OSRAM)
ZA (1) ZA201000126B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
MD4197C1 (ro) * 2012-10-22 2013-09-30 Мария ДАНУ Metodă de tratament al ulcerelor trofice
CN102961336B (zh) * 2012-12-13 2014-08-13 清华大学深圳研究生院 纳米级铂类药物及其制备方法
EP3065708A1 (en) * 2013-11-06 2016-09-14 invenres GmbH Pharmaceutical preparation and method of its production and use
EP3215129A2 (en) * 2014-11-04 2017-09-13 invenres GmbH Pharmaceutical preparation and method of its production and use
CN106558599B (zh) * 2015-09-29 2020-04-07 中芯国际集成电路制造(上海)有限公司 电阻随机存取存储器及其形成方法
WO2019145546A1 (en) 2018-01-29 2019-08-01 Pathelen Health Care Ag Hydrophilic/hydrophobic pharmaceutical composition and method of its production and use
CN108309941B (zh) * 2018-03-20 2023-08-11 南京工业大学 一种舍雷肽酶外用粉剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792160A (en) 1972-01-18 1974-02-12 Takeda Chemical Industries Ltd Method of treating inflammation and composition therefor
JPS5826822A (ja) * 1981-08-10 1983-02-17 Kaken Pharmaceut Co Ltd 慢性腎炎治療剤
CN1234426C (zh) * 2001-07-24 2006-01-04 先进生物技术公司 局部用药物制剂

Also Published As

Publication number Publication date
BRPI0814549B1 (pt) 2018-07-03
HRP20110107T1 (hr) 2011-03-31
WO2009008851A3 (en) 2009-11-26
DK2170415T3 (da) 2010-12-13
CN101772356A (zh) 2010-07-07
US9302027B2 (en) 2016-04-05
BRPI0814549A2 (pt) 2017-10-03
KR101482960B1 (ko) 2015-01-15
US20170368154A1 (en) 2017-12-28
MX2010000367A (es) 2010-07-02
JP2010533174A (ja) 2010-10-21
SI2170415T1 (sl) 2011-02-28
EA016764B1 (ru) 2012-07-30
PT2170415E (pt) 2011-01-05
US10166275B2 (en) 2019-01-01
AU2008275852A1 (en) 2009-01-15
US20160206709A1 (en) 2016-07-21
CA2693087A1 (en) 2009-01-15
CA2693087C (en) 2016-08-16
US9757436B2 (en) 2017-09-12
CN101772356B (zh) 2013-05-08
US20100291062A1 (en) 2010-11-18
US20150297787A1 (en) 2015-10-22
EP2277559A1 (en) 2011-01-26
EP2170415A2 (en) 2010-04-07
JP5464750B2 (ja) 2014-04-09
UA28103U (uk) 2007-11-26
EP2170415B1 (en) 2010-11-17
AU2008275852B2 (en) 2014-02-13
EA201070130A1 (ru) 2010-08-30
DE602008003584D1 (de) 2010-12-30
ES2353683T3 (es) 2011-03-04
ZA201000126B (en) 2011-04-28
WO2009008851A2 (en) 2009-01-15
PL2170415T3 (pl) 2011-04-29
ATE488255T1 (de) 2010-12-15
CY1111652T1 (el) 2015-10-07
KR20100051655A (ko) 2010-05-17

Similar Documents

Publication Publication Date Title
MX2010000367A (es) Composicion antimicrobiana.
WO2007120342A3 (en) Adsorbent-containing hemostatic devices
AU2007211617A8 (en) Hydrogel
IL185211A0 (en) Mineral technologies (mt) for acute hemostasis and for the treatment of acute wounds and chronic ulcers
ATE437662T1 (de) Wundverband mit einem entzündungshemmenden schmerzmittel und einem komplex aus silberion und einem übergangselement der gruppe iv des periodensystems der elemente
MX352822B (es) Composiciones biocidas y métodos para utilizar las mismas.
WO2007136844A3 (en) Systems and methods for enhancing gas and vapor transfer for tissue treatment devices
BRPI0808543B8 (pt) Dispositivo capaz de proporcionar efeito hemostático em ferimento de hemorragia
MY158428A (en) Topical composition for the treatment of actinic keratosis
JP2010533174A5 (OSRAM)
NZ588898A (en) Use of nemonoxacin for treating antibiotic-resistant staphylococcus aureus infection
WO2008080532A3 (de) Medizinisches flächengebilde
ATE533496T1 (de) Azithromycin zur behandlung von knotiger akne
WO2008033866A3 (en) Methods and compositions for the use of lysine riboswitches
UA6357U (en) Complex antibacterial sorptive metrodisil-paste composition for preventing surgical infection and treating purulent wounds, burns, and neurepathic eschar
UA6358U (en) Complex antibacterial sorptive metrocefasil composition for preventing surgical infection and treating peritonitis, purulent wounds, burns, neurepathic eschar, and abscesses
UA6359U (en) Complex antibacterial sorptive metrodicefasil-paste composition for preventing surgical infection and treating purulent wounds, burns, and neurepathic eschar, and method for its manufacture
UA112523U (xx) Комплексний антимікробний сорбційний препарат орнідасил для профілактики аеробної і анаеробної інфекції та лікування гнійних ран, трофічних виразок, опіків
UA27437U (en) Method for treating purulent wounds in pigs
UA120899U (uk) Комплексний антимікробний сорбційний препарат нітасил для профілактики аеробної і анаеробної інфекції та лікування гнійних ран, трофічних виразок, опіків
UA71494U (ru) Применение противобактериального препарата метросила как средства для профилактики хирургической инфекции и лечения перитонита, гнойных ран, трофических язв, ожогов, послеоперационных анаэробных инфекций, хронических ран, инфильтрата с выраженным некротическим и экссудативным компонентом кожного стрептотрихоза в ветеринарной практике
FR2892311B1 (fr) Pansement pour la cicatrisation des plaies, ulceres ou brulures des epitheliums, endotheliums ou muqueuses.
UA130434U (uk) Комплексний антимікробний сорбційний препарат
PL2133079T3 (pl) Kompozycje do leczenia infekcji pochwy z przewlekłym zapaleniem
HK1115335A (en) Mineral technologies (mt) for acute hemostasis and for the treatment of acute wounds and chronic ulcers